Novel use of the Nuwellis® dual extended length catheter (dELC) as umbilical venous access for neonatal kidney replacement therapy: case series.

Pediatr NephrolMay 18, 2026 (epub)
Case ReportPediatricsNephrologyOpen access

Kara Short, Alyssa Umberger, Meggie Mathis et al.

✦ AI-curated · Sources linked

Case in brief

This case series details the use of a 6 French Nuwellis® dual lumen extended length catheter (dELC) for umbilical venous access in four neonates requiring continuous kidney replacement therapy (CKRT). All placements were successful, with blood flow rates between 20-40 mL/min. Complications included one catheter with hub cracks and flow limitations in one patient, while two patients experienced no complications. Half transitioned to tunneled catheters post-therapy.

Diagnostic / clinical pearl

The Nuwellis® dELC may provide a safe and effective alternative for umbilical venous access in neonates requiring CKRT, potentially improving access options in this vulnerable population.

Why it matters

This case series highlights the potential for using umbilical venous access in neonatal CKRT, which is not widely practiced in the USA, suggesting a need for further investigation into its safety and efficacy.

Source

Published in Pediatr Nephrol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.